Beware of the risks of visceral obesity: Scientific weight loss reduces the incidence of chronic diseases.

Obesity, especially visceral obesity, is associated with an increased incidence of various diseases, including cardiovascular disease, diabetes, hypertension, reproductive system diseases, endocrine disorders, and tumors.

Those with a BMI > 29 kg/m² have a 3.3 times higher risk of coronary heart disease than those with a BMI < 21 kg/m². BMI is positively correlated with serum triglyceride levels and negatively correlated with high-density lipoprotein cholesterol. Most studies have confirmed the relationship between obesity and hypertension. The risk of developing type 2 diabetes increases with increasing BMI. Women with a BMI < 24 have the lowest risk of diabetes, but the relative risk increases 40 times when BMI = 35. Obesity may also increase the incidence of gallstones and fatty liver. In recent years, greater attention has been paid to the relationship between fat distribution and obesity prognosis. Even with the same degree of obesity, visceral obesity has a higher incidence of diseases such as glucose metabolism disorders, lipid metabolism disorders, hypertension, coronary heart disease, and fatty liver compared to subcutaneous fat obesity. The risks of visceral obesity are widely recognized.

Diabetes mellitus is a metabolic disease, classified into type 1 diabetes and type 2 diabetes based on its etiology and pathogenesis. Type 1 diabetes is not significantly related to obesity; it is mainly caused by insufficient insulin secretion due to the destruction of pancreatic β-cells. Type 2 diabetes is closely related to obesity; obese patients, especially those with abdominal obesity, exhibit significant insulin resistance. Type 2 diabetes is primarily caused by a series of metabolic disorders resulting from insulin receptor resistance and secondary abnormal insulin secretion. Approximately 80% of patients with type 2 diabetes are obese to varying degrees.